![PDF) Serum tumor markers in the diagnosis of cholangiocarcinoma | Chatchai Trakulrungsi - Academia.edu PDF) Serum tumor markers in the diagnosis of cholangiocarcinoma | Chatchai Trakulrungsi - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/60141564/mini_magick20190728-23424-ktl1sc.png?1564346502)
PDF) Serum tumor markers in the diagnosis of cholangiocarcinoma | Chatchai Trakulrungsi - Academia.edu
![Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023 Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023](https://journals.sagepub.com/cms/10.1177/10668969231157775/asset/images/large/10.1177_10668969231157775-fig6.jpeg)
Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature - Ahmed Bakhshwin, Keith K. Lai, Alwalid Ammoun, Kenneth Friedman, Mohamed El Hag, 2023
![Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach](https://www.mdpi.com/cancers/cancers-14-00362/article_deploy/html/images/cancers-14-00362-g001.png)
Cancers | Free Full-Text | Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
![How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1756231721001778-gr1.jpg)
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect
![Full article: Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy Full article: Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy](https://www.tandfonline.com/cms/asset/67764ec2-cd45-424e-8040-cdd7853f2190/dcmr_a_12189822_f0001_b.jpg)
Full article: Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy
![Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology](https://www.frontiersin.org/files/Articles/768009/fonc-11-768009-HTML/image_m/fonc-11-768009-g001.jpg)
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
![Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | Journal of Cancer Research and Clinical Oncology Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | Journal of Cancer Research and Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00432-020-03200-2/MediaObjects/432_2020_3200_Fig1_HTML.png)
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging | Journal of Cancer Research and Clinical Oncology
![Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-020-0310-z/MediaObjects/41575_2020_310_Fig1_HTML.png)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
![Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type](https://www.frontiersin.org/files/MyHome%20Article%20Library/318545/318545_Thumb_400.jpg)
Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
![Bile Duct Cancer | Cholangiocarcinoma - Causes, Risk Factors, Symptoms, Diagnosis, Stages, Treatment, Support Groups Bile Duct Cancer | Cholangiocarcinoma - Causes, Risk Factors, Symptoms, Diagnosis, Stages, Treatment, Support Groups](https://images.medindia.net/patientinfo/950_400/bile-duct-cancer.jpg)
Bile Duct Cancer | Cholangiocarcinoma - Causes, Risk Factors, Symptoms, Diagnosis, Stages, Treatment, Support Groups
![Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-019-5548-x/MediaObjects/12885_2019_5548_Fig1_HTML.png)